Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at FortreaParticipant: Darby Thomas, Senior Scientific Director for Cell and Gene Therapies, Fortrea Description: In this first e...

Host: Dr. Mala Puri, Senior Medical Director at Fortrea Participant: Dr. Sanjoy Dutta PhD, Chief Scientific Officer at Breakthrough T1DDescription: This episode brings together Mala Puri, Senior Medical D...

Host: Dr. Mala Puri, Senior Medical Director at Fortrea Participant: Dr. Sanjoy Dutta PhD, Chief Scientific Officer at Breakthrough T1DDescription: This episode brings together Mala Puri, Senior Medical D...

Obesity is a serious, chronic disease with multiple health consequences. Effective treatment should go beyond simply reducing body weight. It must focus on decreasing fat mass, improving body composition including preserving muscle mass and enh...

Host: Dr. Friedrich Mittermayer, Sr. Medical Director for Endocrinology, FortreaParticipant: Dr. Esther Latres PhD, VP of Research at Breakthrough T1DDescription: This episode brings together Dr. Friedrich Mit...

In this episode, we hear from Sarah, a patient living with obesity and a passionate advocate, as she shares her personal experience participating in clinical trials. Sarah reflects on the emotional and practical motivations that drive patients ...

In this episode, we hear from Sarah, a patient living with obesity, as she shares her lifelong journey—from early body image struggles and restrictive dieting to participating in a televised weight-loss transformation. Despite achieving peak fi...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea Participants: Abby Fuller, Senior Director of Strategic Delivery Growth in Neuroscience, Fortrea Walter Gonz...

Host: Dr. Cheerag Shirodaria, VP and Cardiovascular/Metabolic Therapeutic Area Head, FortreaParticipant: Chris Farina, Abcentra CEO Description: In episode two, the conversation turns to clinical developm...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at FortreaParticipants:  Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology at Fortrea Alicia Baker, Vice ...

Host: Dr. Cheerag Shirodaria, VP and Cardiovascular/Metabolic Therapeutic Area Head, FortreaParticipant: Chris Farina, Abcentra CEO Description: Despite advances in lipid-lowering and antithrombotic thera...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at FortreaParticipants:  Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology, Fortrea Robin Wolz, Chief Sci...

Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at FortreaParticipants:  Joanie Brown, Head of Operations at our Rapid Development Studio AI/ML, Fortrea Mark Austin, CTO at Ixico&n...

In our third episode, we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials.Our moderator, Dr. Ken Park, is joined by an e...

This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies.Our moderator, Dr. Ken Park, is joined by an exceptional group of speakers: Tracy Ne...

In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and t...

This episode is part of the 'Project Optimus' series exploring oncology trial reform.Overview: Behind every optimized dose is a robust framework of modeling, simulation, and thoughtful study design. Host Abigail Beanie re...

This episode is part of the 'Project Optimus' series exploring oncology trial reform.Overview: Description: How do you bring Project Optimus from concept to clinic? In this episode, Dr. Shanthi Sundaramoorthy, Senior ...

This episode is part of the 'Project Optimus' series exploring oncology trial reform.Overview: What is Project Optimus, and why is it reshaping the future of oncology drug development? In this kickoff episode, we unpack t...

Join us for the fourth episode of our "Sustainability in Clinical Trials" series! 🎧 This 2-part episode delves into the crucial role of partnerships in challenging established thinking of sustainability and clinical trial design. Ho...

Don't miss the third episode of our "Sustainability in Clinical Trials" series! 🎧 In this 2-part episode, host John Kennett and panelists Caleb Tuten, Lisa Moneymaker, Fiona Adshead, and Marlene Knupfer discuss the vital role of par...

Tune in to the second episode of our "Sustainability in Clinical Trials" series! 🎧 This 2-part episode delves into how sustainability strategies drive speed and efficiency in drug development. Host John Kennett is joined by Carly Sa...

Dive into our first episode of the "Sustainability in Clinical Trials" series! 🎧 In this 2-part episode, we explore innovative strategies to drive sustainability and profitability in tandem. Join host John Kennett and our expert pan...

Overview: In this 2-part episode, we look a little beyond clinical trials, taking a complex systems view on how sustainability thinking is shaping the future of healthcare as a whole, and the role that our industry must play in informing...

Overview: In this 2-part episode, we look a little beyond clinical trials, taking a complex systems view on how sustainability thinking is shaping the future of healthcare as a whole, and the role that our industry must play in informing...